Skip to main content
v2026.11,986 entries · CC-BY 4.0

PVSP (CASRAI)

Pharmacovigilance Certification: Drug Safety Professional, PVSP (CASRAI)

An examined CASRAI credential for experienced drug-safety staff: case quality, causality, MedDRA and CTCAE, expedited and aggregate reporting, signals, RMP and REMS.

LevelProfessionalPVSPVSP (CASRAI)
6 h
Nominal
Self-paced study
11
Lessons
Self-paced
8
Domains
Exam blueprint
75
Exam items
Per attempt
70%
Pass mark
Fixed, uncurved
90
Retake wait
Days
3 yr
Valid for
From the pass

What you earn

The credential itself

Pass the examination and CASRAI issues this certificate and the post-nominal PVSP (CASRAI), signed by the Programme Director, valid for 3 years, and checkable by anyone from the verification code on its face.

Specimen. Issued as a signed PDF and as a machine-readable Open Badge; the holder and code shown are illustrative.
How it appears on your CV

Certifications

PVSP (CASRAI) — Pharmacovigilance & Drug Safety, Professional

CASRAI·Issued Mar 2026·Credential ID CASRAI-PVS-2026-CLHYZ9

casrai.org/verify/CASRAI-PVS-2026-CLHYZ9

Every certificate is issued under the signature of Dr. Diana Nieves Castro, MD, Programme Director of CASRAI Certification, who sets the syllabus, blueprint and pass mark for this credential.

It certifies that its holder passed the CASRAI examination for this course on the date shown, scored against the blueprint and pass mark published on this page — and anyone can confirm it from the verification code, without an account and without contacting us.

About this credential

What it covers

Pharmacovigilance & Drug Safety — Professional is an examined CASRAI credential for people who are accountable for drug-safety decisions in clinical development and after approval. Holders use the designation PVSP (CASRAI).

Who it is for

  • Drug-safety physicians, safety scientists and case-processing leads
  • Authors and owners of aggregate reports: DSURs, PBRERs and EU PSURs, and US periodic adverse drug experience reports
  • Signal-detection and signal-management staff, and members of safety review committees
  • Risk management plan authors and REMS programme staff
  • Pharmacovigilance quality, audit and inspection-readiness staff, and PSMF custodians
  • Staff who support an EU QPPV, and academic sponsor-investigators who carry sponsor safety duties

The course assumes you already work in a safety role and know the basic vocabulary of adverse events and reactions. If you are new to drug safety, start with the Foundation tier.

What you will be able to do

  • Settle terminology disputes against the governing definition and jurisdiction: ICH E2A, ICH E2D(R1), 21 CFR 312.32 and GVP Module VI
  • Determine day zero for hard intake cases, including contractors, licensing partners, literature and digital platforms
  • Run duplicate detection, safety-to-clinical reconciliation and compliance metrics that measure what they claim to measure
  • Assess seriousness, expectedness and causality, including reference safety information changes and investigator–sponsor disagreement
  • Code with MedDRA following the Term Selection Points to Consider, plan a MedDRA version change, and grade with CTCAE v6.0
  • Work out every expedited reporting obligation a case triggers under US IND rules, US postmarketing rules, ICH and the EU
  • Choose and assemble the right aggregate report, holding to the data lock point
  • Validate, assess and act on signals, and read disproportionality output within its limits
  • Compare an EU RMP with a US REMS, evaluate risk minimisation, and describe the QPPV role and the PSMF accurately

Modules

  1. Terminology under pressure: definitions, protocol constructs and special situations
  2. Case intake, day zero and triage
  3. Case processing quality, duplicates and reconciliation
  4. Assessment: seriousness, expectedness and causality
  5. MedDRA in practice: term selection, primary SOC, SMQs and versions
  6. CTCAE v6.0 in practice and the version problem
  7. Expedited reporting across jurisdictions
  8. Aggregate reporting: DSUR, PBRER/PSUR and PADER
  9. Signal detection and management
  10. Risk management: EU RMP, risk minimisation and US REMS
  11. Pharmacovigilance systems, the QPPV, the PSMF, audits and inspections

The lessons are written against ICH E2D(R1), the GVP modules in force on EMA’s GVP page, MedDRA Version 29.1 and its Points to Consider documents, and CTCAE v6.0. When a source is revised, the affected lessons and questions are reviewed.

The exam

  • 75 scored multiple-choice questions per attempt, drawn from a larger bank in proportion to the published domain weights
  • Most questions are short workplace scenarios that ask you to apply or analyse the rules, not to recall them
  • Every question that involves a reporting clock names its jurisdiction
  • Pass mark: 70%
  • Must be finished within 4 hours of starting.
  • You must complete every lesson before you can start the exam
  • If you do not pass, you can retake the exam after 90 days

Eligibility

The Foundation tier has no prerequisite. The Professional tier is for experienced practitioners. At checkout you confirm that you meet one of these routes; CASRAI does not ask for documents:

  • Experience: 24 months’ cumulative full-time-equivalent experience in a pharmacovigilance, drug-safety or clinical-safety role within the past 6 years
  • Education plus experience: a completed degree or diploma in medicine, pharmacy, nursing, life sciences, public health, epidemiology or a related discipline, plus 12 months’ such experience
  • Foundation plus experience: PVSF (CASRAI), the Foundation credential, plus 12 months’ such experience

Safety experience includes case intake, triage, processing, medical review, coding, aggregate reporting, signal work, risk management plan work, pharmacovigilance quality and audit, PV systems administration, and safety oversight by a sponsor-investigator or coordinating centre. Site-level adverse event recording counts at half weight.

What the credential is, and what it is not

  • It is an examined credential issued by CASRAI. Each certificate can be verified with CASRAI.
  • It is not accredited, and it carries no CE, CME or CEU credit.
  • It does not meet any statutory, funder, sponsor, employer or institutional training requirement.
  • It is not endorsed by ICH, FDA, EMA, the MHRA, the MedDRA MSSO, NCI or any other regulator, funder or professional body.
  • It does not make anyone eligible to act as a Qualified Person Responsible for Pharmacovigilance (QPPV) in the EU or anywhere else. QPPV requirements are set by EU law, not by any certificate.
  • It certifies knowledge of the safety system, not clinical judgement. It gives no authority to diagnose, treat or decide the medical management of an adverse reaction.

Validity and renewal

Certificates are valid for 3 years. To renew, pass the current version of the exam again. MedDRA changes twice a year and the GVP modules and ICH guidelines are revised, so the exam you renew against reflects the sources current at that time. Course access does not expire, so you can return to the lessons when the rules change.

Body of knowledge

Exam blueprint

The exam is assembled to these weights on every attempt. They are published before purchase because a blueprint you cannot see is not a blueprint.

Domains and weights8 domains · 75 scored items
DomainWeight
Safety terminology and regulatory constructsD1
11%8 items
ICSR lifecycle and case-processing qualityD2
14%11 items
Seriousness, expectedness and causality assessmentD3
13%10 items
MedDRA coding and CTCAE grading in practiceD4
12%9 items
Expedited reporting across jurisdictionsD5
14%10 items
Aggregate reporting: DSUR, PBRER/PSUR and PADERD6
12%9 items
Signal detection and managementD7
12%9 items
Risk management and pharmacovigilance system governanceD8
12%9 items
Total100%

Every attempt has this many items from each domain. The items themselves are drawn at random from the bank within those fixed per-domain quotas, so no two attempts are the same paper.

Syllabus

Syllabus: 11 lessons, 6 hours

Every lesson and every learning outcome is listed. The lesson bodies open on enrolment, and the exam opens once every lesson is marked complete.

11 lessons · 5.8 h

Lesson material opens once you are enrolled. The full syllabus and every learning outcome are shown here so you can judge the coverage before you pay.

  1. Lesson 1

    Module 1

    1 lesson · 30 min

    1. Locked.Terminology under pressure: definitions, protocol constructs and special situations30 min · Locked

      On completion you will be able to

      • Adjudicate a terminology dispute by citing the governing definition and its jurisdiction, and document the decision
      • Draft an SOP definitions section that spans ICH, US and EU vocabularies without merging their terms
      • Identify where a protocol's safety definitions conflict with 21 CFR 312.32 or ICH E2A and state the reporting consequence
      • Classify a described report as an adverse event, an other observation, or both, and state its handling under E2D(R1)
      • Determine whether a described admission meets the hospitalisation criterion and justify the determination
  2. Lesson 2

    Module 2

    1 lesson · 30 min

    1. Locked.Case intake, day zero and triage30 min · Locked

      On completion you will be able to

      • Design an intake workflow that protects day zero across at least six receipt channels
      • Determine day zero for contractor, partner, literature, digital-platform and follow-up cases
      • Classify an ambiguous source as spontaneous or solicited and state its reporting consequence
      • Specify a literature-monitoring process and defend its scope and frequency
      • Diagnose the root cause of a late-report finding and propose a corrective action aimed at the cause
  3. Lesson 3

    Module 3

    1 lesson · 30 min

    1. Locked.Case processing quality, duplicates and reconciliation30 min · Locked

      On completion you will be able to

      • Execute a duplicate-detection process and defend each match or non-match
      • Apply the Addendum II masking lists to a described ICSR and state which fields must still be sent
      • Specify a safety-to-clinical reconciliation and adjudicate its discrepancies before database lock
      • Define compliance and quality metrics that cannot be satisfied by misclassification
      • Write a CAPA whose action addresses the root cause of a described finding
  4. Lesson 4

    Module 4

    1 lesson · 30 min

    1. Locked.Assessment: seriousness, expectedness and causality30 min · Locked

      On completion you will be able to

      • Adjudicate a contested seriousness determination and document the reasoning against the criterion
      • Determine the effect of an RSI change on reportability, going forward and for reports already made
      • Apply the specificity and severity rule to determine whether a reaction is unexpected
      • Manage an investigator-sponsor causality disagreement without removing reportability
      • Evaluate a causality assessment method against its stated assumptions
      • Determine when a rate increase in an expected reaction is itself reportable
  5. Lesson 5

    Module 5

    1 lesson · 30 min

    1. Locked.MedDRA in practice: term selection, primary SOC, SMQs and versions30 min · Locked

      On completion you will be able to

      • Code verbatim terms to LLTs following MTS:PTC and defend the choice against alternatives
      • Explain primary SOC allocation, including the three exception SOCs and their priority
      • Construct an SMQ retrieval at narrow and broad scope and state the trade-off
      • Plan a MedDRA version upgrade and describe its effect on historical data and cumulative output
      • Author a coding convention and apply it consistently to a case set
  6. Lesson 6

    Module 6

    1 lesson · 30 min

    1. Locked.CTCAE v6.0 in practice and the version problem30 min · Locked

      On completion you will be able to

      • Grade an event using CTCAE v6.0 term-specific criteria
      • Explain, with an example, why a CTCAE grade never determines seriousness
      • Apply Navigational Notes and the Grade 5 conventions to avoid double reporting of an event or a death
      • Reconcile a CTCAE-graded dataset with MedDRA-coded safety data across versions
      • Identify a version-alignment defect in a protocol or statistical analysis plan and write the corrected text
  7. Lesson 7

    Module 7

    1 lesson · 30 min

    1. Locked.Expedited reporting across jurisdictions30 min · Locked

      On completion you will be able to

      • Determine every expedited reporting obligation a described case triggers in each jurisdiction where the product is in development or authorised
      • Calculate the due date and recipients for US 7-day and 15-day IND safety reports from receipt and determination dates
      • Name the destination and format for each obligation
      • Determine whether and by whom a blinded case should be unblinded for reporting
      • Distinguish the sponsor's regulatory obligation, the investigator's obligation and the IRB/IEC requirement
      • Diagnose and remediate a compliance failure against a named clock
  8. Lesson 8

    Module 8

    1 lesson · 30 min

    1. Locked.Aggregate reporting: DSUR, PBRER/PSUR and PADER30 min · Locked

      On completion you will be able to

      • Select the correct aggregate report or reports for a product's regulatory status and jurisdiction
      • Determine the data lock point, reporting interval and submission deadline for a DSUR, PBRER/PSUR or PADER
      • Assemble interval and cumulative datasets that reconcile to the stated data lock point
      • Draft and defend a benefit-risk evaluation and signal overview section
      • Identify missing required content in a draft US periodic report
  9. Lesson 9

    Module 9

    1 lesson · 45 min

    1. Locked.Signal detection and management45 min · Locked

      On completion you will be able to

      • Interpret a disproportionality result and state what it does and does not support
      • Validate a signal and document the validation against the GVP IX definition
      • Prioritise, assess and close signals with documentation at each step
      • Determine what action and notification a confirmed signal or emerging safety issue requires, and by when
      • Design a detection strategy proportionate to a product's data sources and database size
  10. Lesson 10

    Module 10

    1 lesson · 30 min

    1. Locked.Risk management: EU RMP, risk minimisation and US REMS30 min · Locked

      On completion you will be able to

      • Critique an RMP against the product's safety specification
      • Distinguish routine from additional risk minimisation and specify how effectiveness will be measured
      • Describe the statutory REMS elements and assessment timetable
      • Distinguish a REMS from an RMP for a product marketed in both regions
      • Evaluate whether a proposed risk minimisation measure is proportionate to the risk
  11. Lesson 11

    Module 11

    1 lesson · 30 min

    1. Locked.Pharmacovigilance systems, the QPPV, the PSMF, audits and inspections30 min · Locked

      On completion you will be able to

      • Describe the components of a pharmacovigilance system and locate a described failure within it
      • State the QPPV's legal position accurately, including residency, availability, back-up and delegation, and what the role does not mean
      • Describe the PSMF's function, location and maintenance
      • Distinguish audits from inspections and describe the inspection types
      • Prepare a corrective and preventive action response to a described inspection finding

Assessment

How the exam works

The exam is closed-book and multiple choice. Each attempt draws a fresh form to the domain weights above, so no two attempts are the same paper and no answer key circulates. The pass mark is 70% and is fixed — there is no curve, no quota and no adjustment by cohort.

Scoring is immediate. Pass, and every item is reviewed with the option you chose, the correct option and its rationale. If you do not pass, you see your overall score and your score per domain (smaller domains are grouped together); which items you missed, and their answers, are held back so your resit is still a real assessment. A failed attempt may be retaken after 90 days. The wait exists so a retake is a second attempt at the material rather than a second attempt at remembering the paper.

The exam opens once you have marked every lesson of the course complete. Forms are assembled to the blueprint above or not at all: where a domain cannot yet be sampled to that standard, the exam declines to start rather than issue an unbalanced paper. Your material and progress are never affected, and there is no time limit on when you sit.

Passing candidates are issued a certificate with a verification code, valid for 3 years from the date of the pass. Anyone can check that code on our public verification page without an account and without contacting us. To renew, pass the current examination again: renewal opens 180 days before the certificate expires, and a pass issues a renewed certificate valid for a further 3 years from that date.

Certifying authority

Signed by Dr. Diana Nieves Castro, MD

CASRAI’s certification programme is academically and medically directed by Dr. Diana Nieves Castro, MD, Programme Director, who sets the syllabus and blueprint for this credential and signs every certificate issued under it.

CASRAI has maintained the terminology and reporting standards of research administration for over a decade. It assumed leadership of the CRediT contributor-roles taxonomy in 2014 and carried it through to adoption as ANSI/NISO Z39.104-2022, now in use by publishers, funders and institutions worldwide. This examination is drawn from that body of work.

What the credential certifies: that its holder passed the CASRAI examination for this course on the date shown, scored against the blueprint and pass mark published above. It is valid for 3 years, and anyone can check it from the verification code on its face.

The ladder

Other levels of Pharmacovigilance & Drug Safety

Levels are independent purchases. There is no prerequisite chain — sit whichever level matches the work you already do.

All CASRAI credentials

Common questions

Pharmacovigilance Certification: Drug Safety Professional, PVSP (CASRAI): common questions

What are some available certification courses in pharmacovigilance?

PVSP (CASRAI) is an examined pharmacovigilance credential issued by CASRAI: 11 lessons (about 6 study hours) on case intake and processing quality, causality, MedDRA and CTCAE in practice, expedited reporting across jurisdictions, DSUR and PBRER/PSUR, signal management and RMP/REMS. It costs US$279 as a one-time card payment, and course access does not expire. New safety staff can start with the Foundation tier, PVSF (CASRAI).

How to get into pharmacovigilance?

If you are new to drug safety, start with the Foundation tier, which has no prerequisite. The Professional tier is for experienced practitioners: at checkout you confirm that you meet one route, either 24 months' pharmacovigilance or drug-safety experience in the past 6 years, a relevant degree plus 12 months' such experience, or PVSF (CASRAI) plus 12 months' such experience.

Do you need a pharmacovigilance certificate?

Whether you need one depends on the role and the employer, and PVSP (CASRAI) does not meet any statutory, sponsor or employer training requirement. It is not accredited, carries no CE, CME or CPD credit, and does not make anyone eligible to act as an EU QPPV. What it gives you is examined evidence of applied safety knowledge, with a 70% pass mark and a public verification page for each certificate.

What is the PVSP exam like?

The exam is an online multiple-choice test of 75 questions with 4 options each, drawn from the course bank across eight weighted domains, and the pass mark is 70%. It unlocks once you have completed all lessons and must be finished within 4 hours of starting. It is not proctored, and after a failed attempt you can retake it after a 90-day waiting period.

How long is the pharmacovigilance certificate valid?

The certificate is valid for 3 years. You renew by passing the current version of the exam again, and the renewal window opens 180 days before expiry. Each certificate has its own public verification page on casrai.org.

Referenced across the research world

University of Cambridge logoColumbia University logoCrossref logoUniversity of Edinburgh logoHarvard University logoUniversity of Oxford logoPrinceton University logoStanford School of Medicine logoUniversity College London logoORCID logoUniversity of Cambridge logoColumbia University logoCrossref logoUniversity of Edinburgh logoHarvard University logoUniversity of Oxford logoPrinceton University logoStanford School of Medicine logoUniversity College London logoORCID logo
  • University of Cambridge logo
  • Columbia University logo
  • Crossref logo
  • University of Edinburgh logo
  • Harvard University logo
  • University of Oxford logo
  • Princeton University logo
  • Stanford School of Medicine logo
  • University College London logo
  • ORCID logo

View CASRAI adoption →